UNIVERSAL EXERCISE UNIT and REBOUND THERAPY ON GENU RECURVATUM Cerebral Palsy Childeren

Not Applicable

Active, not recruiting

• Conditions: Genu Recurvatum

• Registration Number: NCT07008521
• Lead Sponsor: Cairo University

Brief Summary

to investigate and compare between effectiveness of Universal Exercise Unit and Rebound Therapy on genu recurvatum, muscle strength, balance, functional mobility and quality of life in spastic cerebral palsy children

Detailed Description

Children will be equally assigned into three groups using simple randomization, control group, study group (A) and study group (B). Each group will consist of 20 children with spastic CP to overcome any drop out may occur.

Control group: Children in this group will receive a traditional physical therapy program.

Study group (A): Children in this group will receive a traditional physical therapy program in addition to universal exercise unit program.

Study group (B): Children in this group will receive the same traditional physical therapy program in addition to rebound therapy.

Evaluation will be carried out for each child individually before and after 3 months of treatment.

Study Timeline

• Status Verified: 2024-08
• Study Start: 2025-03-01
• Study First Submitted: 2025-05-29
• Study First Submitted QC: 2025-05-29
• Last Update Submitted: 2025-05-29
• Study First Posted: 2025-06-06
• Last Update Posted: 2025-06-06
• Primary Completion: 2025-09-01
• Study Completion: 2025-10-01

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• -Children with spastic CP both hemiplegic and diplegic.
• Their ages will be ranged from 5-7 years old.
• They will have mild spasticity (grade 1 and 1+) according to Modified Ashworth scale .
• They will be in level I and II according to gross motor function classification system (GMFCS) .
• They will be able to understand orders given to them.

Exclusion Criteria

• Subjects will be excluded if they have the following:

  1. Visual or hearing impairment.
  2. Severe limb deformities as structural genurecurvatum.
  3. Surgical interference in the lower limbs for the last 6 months.
  4. Botulinum toxin injection of the spastic lower limb muscles during the last six months.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
degree of genu recurvatum	10 minutes	degree of genu recurvatum will be measured by Radiological X-Ray

Secondary Outcome Measures

Name	Time	Method
muscle power	2 minutes	muscle power will be assessed by using Lafayette Manual Muscle Tester
balance	20 minutes	Balance will be assessed by Pediatric Balance Scale
functional mobility	20 minutes	Functional mobility will be assessed by Mobility Questionnaire (Mob Quest 28 )
Quality of child life	20 minutes administration for each child	Quality of life will be assessed by using Pediatric Quality of Life Inventory (PedsQL) scale

Trial Locations

Locations (1)

Faculty of Physical Therapy; 🇪🇬 Giza, Egypt